Acute otitis media: making sense of recent guidelines on antimicrobial treatment; several new recommendations could influence treatment choices

Journal of Family Practice, April, 2005 by Michael E. Pichichero, Janet R. Casey

ACKNOWLEDGMENTS

Dr Pichichero has received grants/research support from Abbott Laboratories, Aventis, Bristol-Myers Squibb, GlaxoSmithKline, and Johnson & Johnson; he has served as a consultant to Abbott, Aventis, and GlaxoSmithKline. Dr Evans has received grants/research support from Abbott Laboratories, Bristol-Myers Squibb, GlaxoSmithKline, and Johnson & Johnson.

REFERENCES

(1.) Pelton SI. Otitis media. In: Principles and Practice of Pediatric Infectious Diseases, Long SS, et al, eds. Philadelphia, Pa: Churchill Livingstone; 2003: chap 27.

(2.) Dowell SF, Butler JC, Giebink GS. Acute otitis media: management and surveillance in an era of pneumo coccal resistance. Nurse Pract 1999; 24(10 Suppl): 1-9.

(3.)Pichichero ME, Reiner SA, Brook I, et al. Controversies in the medical management of persistent and recurrent otitis media. Ann Otol Rhinol Laryngol 2000; 109:2-12.

(4.) American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Clinical practice guideline: Diagnosis and management of acute otitis media. Pediatrics 2004; 113:1451-1466.

(5.) Heikkinen T, Ruuskanen O. Signs and symptoms predicting acute otitis media. Arch Pediatr Adolesc Med 1995; 149:26-29.

(6.) Kontiokari T, Koivunen P, Niemala M, Pokka T, Uhari M. Symptoms of acute otitis media. Pediatr Infect Dis J 1998; 17:676-679.

(7.) Pichichero ME. Acute otitis media: Part I. Improving diagnostic accuracy. Am Fam Physician 2000; 61:2051-2056.

(8.) Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Ped Infect Dis J 2004; 23:824-828.

(9.) Barnett ED, Klein JO. The problem of resistant bacteria for the management of acute otitis media. Pediatr Clin North Am 1995; 42:509-617.

(10.) Doern GV, Pfaller MA, Kugler K, Freeman J, Jones RN. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis 1998; 27:764-770.

(11.) Doern GV, Jones RN, Pfaller MA, Kugler K. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antibacterial susceptibility patterns from the SENTRY antibacterial surveillance program (United States and Canada, 1997). J Antimicrob Chemother 1999; 43:385-389.

(12.) Pichichero ME. Acute otitis media: Part II. Treatment in an era of increasing antibiotic resistance. Am Fam Phys 2000; 61: 2410-2416.

(13.) Marcy M, Takata GS, Shekelle P, et al. Management of acute otitis media. Evidence report/technology assessment no. 15. AHRQ Publication No. 01-E010. Rockville, Md: Agency for Healthcare Research and Quality; 2001.

(14.) Wald ER. Acute otitis media: more trouble with the evidence. Pediatr Infect Dis J 2003; 22:103-104.

(15.) Wandstrat TL, Kaplan B. Pharmacoeconomic impact of factors affecting compliance with antibiotic regimens in the treatment of acute otitis media. Pediatr Infect Dis J 1997; 16(Suppl):S27-S29.

(16.) Block SL, McCarty JM, Hedrick JA, et al. Comparative safety and efficacy of cefdinir vs amoxicillin/clavulanate for treatment of suppurative acute otitis media in children. Pediatr Infect Dis J 2000; 19(Suppl): S159-S165.